Amicus, Inc. Sustainability Profile
Amicus, Inc., a leading player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2002, the company has made significant strides in developing innovative therapies for rare genetic disorders, particularly focusing on enzyme replacement therapies. Amicus is renowned for its flagship product, Galafold, which offers a unique treatment approach for Fabry disease, setting it apart in the competitive landscape. With a commitment to advancing patient care, Amicus has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its market position. As a pioneer in the biopharmaceutical industry, Amicus, Inc. continues to drive progress in the treatment of complex diseases, solidifying its reputation as a trusted name in biotechnology.
DitchCarbon Score
How does Amicus, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amicus, Inc.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amicus, Inc.'s reported carbon emissions
Amicus, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Amicus, Inc. may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the company operates within an industry increasingly focused on sustainability, it may benefit from developing and communicating clear climate commitments to align with global standards and expectations.
How Carbon Intensive is Amicus, Inc.'s Industry?
How Carbon Intensive is Amicus, Inc.'s Location?
Amicus, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amicus, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
